Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
0.8694
+0.1513 (21.07%)
At close: Mar 23, 2026, 4:00 PM EDT
0.9170
+0.0476 (5.48%)
Pre-market: Mar 24, 2026, 9:00 AM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $4.37 million as of March 24, 2026. Its market cap has decreased by -99.97% in one year.
Market Cap
4.37M
Enterprise Value
11.04M
1-Year Change
-99.97%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.65M to $4.37M, a decrease of -98.75%. That is a compound annual growth rate of -67.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 4.37M | -69.19% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.30M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.16M | 5.86% |
| Apr 11, 2022 | 349.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 4.36M |
| Biodexa Pharmaceuticals | 4.34M |
| Aptevo Therapeutics | 4.27M |
| Matinas BioPharma Holdings | 4.10M |
| Silexion Therapeutics | 4.06M |
| Indaptus Therapeutics | 3.81M |
| Purple Biotech | 3.70M |
| GRI Bio | 3.41M |